PANI, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 156.212
NA - Nord America 9.678
AS - Asia 4.417
SA - Sud America 554
Continente sconosciuto - Info sul continente non disponibili 155
AF - Africa 86
OC - Oceania 6
Totale 171.108
Nazione #
IT - Italia 151.468
US - Stati Uniti d'America 9.540
NL - Olanda 1.894
CN - Cina 1.762
SG - Singapore 1.590
UA - Ucraina 827
SE - Svezia 578
BR - Brasile 422
DE - Germania 395
VN - Vietnam 329
FI - Finlandia 315
GB - Regno Unito 299
FR - Francia 230
HK - Hong Kong 181
IN - India 124
KR - Corea 100
BD - Bangladesh 83
CA - Canada 74
AR - Argentina 51
RU - Federazione Russa 42
IQ - Iraq 33
PL - Polonia 33
JP - Giappone 27
MX - Messico 26
EC - Ecuador 25
ES - Italia 23
PK - Pakistan 23
TR - Turchia 23
BE - Belgio 22
ID - Indonesia 21
ZA - Sudafrica 20
MA - Marocco 18
CO - Colombia 17
PH - Filippine 16
SA - Arabia Saudita 16
VE - Venezuela 16
IE - Irlanda 15
MY - Malesia 12
UZ - Uzbekistan 11
MU - Mauritius 10
AT - Austria 9
CZ - Repubblica Ceca 9
LT - Lituania 9
JO - Giordania 8
CR - Costa Rica 7
KE - Kenya 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CL - Cile 6
DZ - Algeria 6
HU - Ungheria 6
IL - Israele 6
JM - Giamaica 6
LB - Libano 6
CH - Svizzera 5
EG - Egitto 5
EU - Europa 5
GT - Guatemala 5
NP - Nepal 5
PE - Perù 5
RO - Romania 5
AZ - Azerbaigian 4
IR - Iran 4
NG - Nigeria 4
SV - El Salvador 4
TN - Tunisia 4
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LY - Libia 2
MM - Myanmar 2
NI - Nicaragua 2
PT - Portogallo 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
Totale 170.944
Città #
Cagliari 148.641
Uta 2.292
Amsterdam 1.876
Singapore 861
Ashburn 761
Woodbridge 736
Fairfield 733
Chandler 706
San Jose 561
Houston 555
Boardman 474
Jacksonville 453
Ann Arbor 434
Dallas 380
Wilmington 378
Beijing 337
Nyköping 336
Seattle 290
Cambridge 248
Dearborn 207
Helsinki 182
Hefei 180
Hong Kong 159
Los Angeles 151
Nanjing 147
Santa Clara 144
Lauterbourg 124
Shanghai 119
Council Bluffs 117
New York 101
Boston 100
Ho Chi Minh City 100
Seoul 93
Buffalo 88
Milan 77
Hanoi 75
The Dalles 70
Shenyang 63
Nanchang 58
Guangzhou 53
São Paulo 43
Columbus 42
Hebei 40
Jiaxing 39
Redwood City 38
Rome 37
San Diego 37
Verona 35
Orem 32
Toronto 32
Brooklyn 29
Jinan 29
Changsha 28
Dong Ket 28
Mountain View 27
Falls Church 25
Tianjin 25
Warsaw 25
Munich 22
Tokyo 21
Brussels 20
Pune 20
Redondo Beach 20
Norwalk 19
Washington 19
Zhengzhou 19
Phoenix 18
Chicago 17
Frankfurt am Main 17
London 17
San Francisco 17
Atlanta 16
Chennai 16
Da Nang 15
Montreal 14
Palermo 14
Rio de Janeiro 14
Auburn Hills 13
Dublin 13
Haiphong 13
Manchester 13
Stockholm 13
Baghdad 12
Mumbai 12
Orange 12
Hangzhou 11
Kunming 11
Ningbo 11
Curitiba 10
Denver 10
Sassari 10
Taizhou 10
Mexico City 9
Philadelphia 9
Quito 9
Wuhan 9
Johannesburg 8
New Delhi 8
Newark 8
Tashkent 8
Totale 164.628
Nome #
Mixed thiophene-phenanthroline Cu(II) complexes: synthesis, equilibria and cytotoxicity 4.847
Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study 4.351
Mixed thiophene-phenanthroline Cu (II) complexes: synthesis, antiviral and antiproliferative activity 4.206
1H NMR brain metabonomics of scrapie exposed sheep 4.050
Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4) 3.974
Novel coumarins and related copper complexes with biological activity: DNA binding, molecular docking and in vitro antiproliferative activity 3.678
Lipid profiles in brains from sheep with natural scrapie 3.486
Mixed-1,10-phenanthroline-Cu(II) complexes: Synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione 3.330
Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks 3.268
Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC 3.215
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.206
New Ruthenium (III) complexes with antitumor activity: design, synthesis and characterization 3.143
Platinum complexes with 1,10-phenanthroline derivatives: synthesis, kinetics and in vitro cytotoxicity. 3.106
null 3.087
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 3.037
Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells 3.023
Synergistic effects of copper(II) complexes and cisplatin: an application of artificial neural networks and experimental design 2.920
Synergistic cytotoxicity of copper(II) complexes in combination with cisplatin: an application of artificial neural networks and experimental design 2.833
Cisplatin, glutathione and the third wheel: a copper-(1,10-phenthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin 2.681
Biochemical and molecular modifications in sheep brains during natural scrapie. 2.627
RT-QuIC detection of PrPsCJD spiked into human urine 2.622
RT-QuIC assay for the detection of PrPsCJD spiked into human urine 2.603
Drug Discovery: towards the identification and characterization of new lead compounds as anticancer and antiprion agents 2.537
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease 2.501
Drug Discovery: towards the identification and characterization of new lead compounds for the design of new anticancer and antiprion agents 2.499
Altered cholesterol ester cycle in ex vivo skin fibroblasts from Alzheimer patients 2.456
Biochemical and molecular modifications in sheep brains during natural scrapie 2.441
Influence of hydrocortisone on cytopathic effect of Newcastle disease virus and stability to freezing of vescicular stomatitis virus 2.403
Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains 2.331
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.299
Cholesterol homeostasis and prion misfolding: a comparative study in mouse neuroblastoma cells and in sheep brains and skin fibroblasts 2.299
Altered proteolysis in fibroblasts of alzheimer patients with predictive implications for subjects at risk of disease 2.258
Intra and intercellular distribution pf mitochondrial probes: a comparison between TMRM and JC-1 2.217
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.133
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays 2.133
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays. XII Congresso Federazione Italiana Scienze della Vita (FISV). Universita` La Sapienza Roma (Italia), 24-27 Settembre 2012. 2.091
Studies on role of cholesterol in the pathogenesis of prion disorders 2.088
null 1.934
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.895
null 1.848
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.820
Ultrasensitive detection of prion seeding activity by RT-QuIC and eQuIC assays for early diagnosis of prion diseases 1.720
Cholesterol Metabolism in Brain and Skin Fibroblasts from Sarda Breed Sheep With Scrapie-resistant and Scrapie-susceptible Genotypes 1.684
null 1.664
ACAT1, Cav-1, and PrP expression in brains and skin fibroblasts from Sarda breed sheep with scrapie-resistant and scrapie-susceptible genotype 1.232
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.227
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 1.220
Neurodegenerative diseases and protein misfolding: novel targets and new inhibitors 1.166
1 ß ribofuranosyl pyrazolo derivati e relativo processo di produzione e impiego farmacologico 1.163
null 1.142
null 1.133
Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126. 1.090
MDR1 cholesterol esterification and cell growth. A comparative study in normal and multidrug resistant KB cell lines 999
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition 972
Changes in cholesterol metabolism in peripheral cells of Alzheimer disease patients and their relatives 971
Possibile nuovo biomarker diagnostico di malattia di Alzheimer: gli esteri del colesterolo 950
Derivatives of the new ring system indolo (1,2-c) benzo (1,2,3) triazine with potent antitumor and antimicrobial activity 855
Intra- and intercellular distribution of mitochondrial probes and changes after treatment with MDR modulators 812
Synthesis, solution equilibria and cytotoxic activity of new copper(II) complexes with 1,10-phenanthroline derivatives 781
Correlation between cholesterol esterification MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines 766
Cholesterol metabolism in brain and skin fibroblasts from Sarda breed sheep with scrapie resistant or susceptible genotype 737
Protein misfolding diseases: novel targets and new inhibitors 704
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 692
Synthesis, structural characterisation, complex formation constants and in vitro cytotoxicity of some copper(II) complexes 663
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 636
Synthesis and antiproliferative acticity of basic thioanalogues of merbarone 629
Nuovi composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus 618
Pyrazole related nucleosides. Synthesis and antiviral / antitumor activity of some substituted pyrazole and pyrazolo [4,3-d]1,2,3-triazin-4-one nucleosides 612
Antiviral activity of glycyrrhizic acid 592
Glycyrrhizic acid inhibits virus growth and inactivates virus particles 577
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells 566
Anti-prion activity of cholesterol esterification modulators: a comparative study in ex vivo sheep fibroblasts and lymphocytes and in mouse neuroblastoma cell lines 557
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration 527
Translational control in L-cells infected by Vesicular Stomatitis Virus or Mengovirus 523
Pyrazole-related nucleosides. Design, synthesis and antiproliferative activity of methyl 4-iodo-1--D -ribofuranosyl-pyrazole-3-carboxylate (IPCAR) and derivatives, against human leukemia, lymphoma and solid tumor cell lines in vitro 518
Prpspettive in tema di antivirali 509
Inactivation by freezing of vesicular stomatitis virus treated with hydrocortisone 504
On the inhibitory effect of 2-amino-4,6-pyrimidines. 496
Oligodeossinucleotidi nativi selettivamente attivi in vitro contro il virus dell'immunodeficienza umana di tipo 1: ruolo del G-quartet. 494
Variation in resistance of cells from inbred strains of mice to herpes simplex virus type 1 460
Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines 457
Synthesis, biological evaluation and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitro imidazoles targeted at the HIV-1 reverse transcriptase 454
Synthesis of new disoxaril analogues with potent and selective anti-HRV-14 activity 452
Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients 446
Characterization and role in morphogenesis of a new subviral particle (55S) isolated from polio infected cells 441
A Kinase able to phosphorylate exogenous protein synthesis initiation factor eIF 2a is present in lysates of mengovirus infected L cells 434
Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artefactual production of procapsids 433
Prophylactic and/or therapeutic treatment of proliferative and conformational diseases 425
HIV-1 integrase inhibitors that block HIV-1 replication in infected cells: planning synthetic derivatives from natural products 420
On the antiviral action of glycyrrhized acid. II. Non involvement of cell membrane transport of ions and metabolites in the antiviral effect 416
Neutral Lipid Determination in Peripheral Blood Mononuclear Cells: A Useful Tool for Diagnostic and Therapeutic Interventions in Dementia 408
Perspectives in antiviral chemotherapy 403
CELL GROWTH AND CHOLESTEROL ESTERS 398
Antiherpes activity of 5 (2 bromoethyl)2' deoxyuridine 387
Models for viral resistance or dependence 380
Design, Synthesis, SAR, and Molecular Modeling Studies of Acylthiocarbamates: A Novel Series of Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Structurally Related to Phenethylthiazolylthiourea Derivatives 379
Pyocianine-induced DNA breakage and repair 376
null 374
On the inhibitory effect of 2 amino 4,6 dichloropyrimidine on growth of vaccinia virus 366
Synthesis and evaluation of anti HIV 1 and antitumor activity of 2',3' didehydro 2', 3' dideoxy 3 deazaadenosine, 2',3' dideoxy 3 deazaadenosine and some 2',3' dideoxy 3 deaza adenosine 5' dialkylphosphates 365
Totale 156.851
Categoria #
all - tutte 223.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 223.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.462 0 899 465 592 895 617 578 349 473 779 843 972
2022/202310.222 949 1.074 1.166 912 978 1.206 433 817 733 637 823 494
2023/202411.274 573 498 530 827 1.073 1.557 1.708 818 565 833 1.250 1.042
2024/202517.322 2.468 5.066 2.680 1.885 1.278 1.269 1.498 150 283 161 242 342
2025/20268.857 423 441 847 624 583 511 1.157 340 2.337 746 474 374
2026/2027427 130 297 0 0 0 0 0 0 0 0 0 0
Totale 171.108